AMI Asset Management’s Verona Pharma VRNA Stock Holding History

AMI Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,624	Closed	-$2.14M	–	93
2025 Q2	$2.14M	Sell	22,624 -19,561	-46%	-$1.45M	0.12%	37
2025 Q1	$2.68M	Sell	42,185 -1,620	-4%	-$96.9K	0.16%	40
2024 Q4	$2.03M	Sell	43,805 -22,541	-34%	-$846K	0.11%	42
2024 Q3	$1.91M	Sell	66,346 -3,654	-5%	-$89.9K	0.1%	44
2024 Q2	$1.01M	Buy	+70,000	New	+$1.02M	0.05%	69

Other funds holding VRNA

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AMI Asset Management's VRNA Position: Q3 2025 in Review

AMI Asset Management sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 22,624 shares — an estimated $2.14M sold.

AMI Asset Management first reported a position in VRNA in Q2 2024 and held it in 5 quarters. The position peaked at $2.68M in Q1 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

AMI Asset Management reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
AMI Asset Management sold 22,624 Verona Pharma shares in Q3 2025, an estimated $2.14M.
AMI Asset Management first reported a position in Verona Pharma in Q2 2024 and held it in 5 quarters.
AMI Asset Management's Verona Pharma position peaked at $2.68M in Q1 2025.
243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on AMI Asset Management's 13F filing for Q3 2025, filed 16 Oct 2025.